For the active substances difenoconazole, diflufenican, extract from tea tree, flurochloridone, indolylbutyric acid, plant oils/clove oil and plant oils/spear mint oil, the Authority needs additional time to reach a conclusion on the risk assessment. Taking into account the subsequent steps to be completed in each renewal procedure, the duration of the extension of the approval periods of these active substances should be set at 19 months and 15 days for diflufenican and flurochloridone, at 22 months and 15 days for difenoconazole, extract from tea tree and indolylbutyric acid, at 23 months and 15 days for plant oils/spear mint oil, and at 29 months for plant oils/clove oil.
Recital 29, Regulation (EU) 2025/2316
In forcesince 17 Nov 2025